• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.36% Nasdaq Down 0.32%

    Ironwood Pharmaceuticals, Inc. (IRWD)

    -NasdaqGS
    16.00 Up 0.02(0.13%) 9:52AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:15.98
    Open:15.95
    Bid:15.84 x 100
    Ask:15.97 x 300
    1y Target Est:14.04
    Beta:1.51
    Earnings Date:Jan 26 - Jan 30 (Est.)
    Day's Range:15.70 - 16.02
    52wk Range:9.01 - 16.49
    Volume:25,873
    Avg Vol (3m):849,910
    Market Cap:2.23B
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IRWDUp 0.13%2.23B
    SHPGUp 1.37%42.89B
    SCMPUp 1.58%675.47M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):51.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.32
    Quarterly EPS Est (Dec-14) :-0.21
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-0.64

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company’s lead product candidate, linaclotide, a guanylate cyclase type-C agonist for irritable... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback